Creative Biostructure Established Advanced COVID-19 Targeted Discovery Platform to Accelerate Scientific Research

February 28 03:24 2020
Creative Biostructure, an expert in the structural biology field, recently established an advanced COVID-19 targeted discovery platform.

Creative Biostructure, an expert in the structural biology field, recently established an advanced COVID-19 targeted discovery platform, offering a wide variety of products and services to help accelerate research for structure/function study and novel drug discovery.

The 2019 novel coronavirus (tentatively named 2019-nCoV) is an infectious virus that can cause respiratory infections. From genome sequencing, it has been shown to be a sense single-stranded RNA coronavirus. The virus was first detected in Wuhan, China in mid-December 2019 and subsequently spread to all provinces of China as well as more than twenty countries in the world.

The main goal of global health efforts targeting COVID-19 remains to effectively isolate patients and screen individuals who may become infected to limit transmission. Creative Biostructure is committed to providing an advanced, complete and professional research service package for COVID-19 and has established the platform to improve human health for the discovery of new vaccines/antibodies.

Featured services and products include:

Expression and purification of COVID-19 structural proteins

Creative Biostructure provides multiple approaches for expression and purification of coronavirus structural proteins, including Cell-based Protein Expression, Cell-free Protein Expression, Virus-like Particle (VLP) Construction, Nanodiscs Construction, and Liposome-based Protein Construction.

Structural characterization of COVID-19 proteins

Creative Biostructure provides sophisticated 3-D structure determination methods for the functional study of COVID-19 including NMR, X-ray Crystallography, and Cryo-Electron Microscopy.

COVID-19 related products

A wide range of virus-like particle (VLP) related products that can be used for functional characterization of COVID-19 are available.

“Utilizing the power of science is of great importance to bring this outbreak under control. As there’s still a lot of unknown factors and tools needed to be developed, we hope our services related could do some help.” said Joanna, the official speaker from Creative Biostructure.

More detailed information about the COVID-19 Targeted Discovery Platform in Creative Biostructure can be viewed here:

About Creative Biostructure

Creative Biostructure is specialized in providing contract services to both academia and biotech/pharmaceutical industries in the field of structural biology. The company offers insightful strategies and cost-effective services on structure determination of macromolecules using X-ray Crystallography, EM, NMR, etc.

Media Contact
Company Name: Creative Biostructure
Contact Person: Jerry Carter
Email: Send Email
Phone: 1-631-619-7922
Country: United States